| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |